Literature DB >> 10439362

High-grade transformation of low-grade non-Hodgkin's lymphomas: mechanisms of tumor progression.

A Matolcsy1.   

Abstract

In the natural history of low-grade non-Hodgkin's lymphomas (NHL) a prolonged indolent phase of the disease may be followed by clinical progression toward intermediate and high-grade disease. The abrupt appearance of diffuse large cell lymphoma (DLL) in patients with low-grade NHL is usually associated with an accelerated clinical course and shorter time of survival. The histologic transformation has been described for chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL), follicular lymphoma (FL), mantle cell lymphoma (MCL) and lymphoma of mucosa-associated lymphoid tissue (MALT). Although the histological transformation of low-grade lymphomas are relatively frequent, the clonal relationship between the two neoplasms and pathogenetic mechanisms underlying the progression of the disease are widely debated. In this review, we will focus on the possible relationship between the low-grade and the transformed high-grade NHLs and genetic lesions that may be associated with the histologic transformation and clinical progression of the disease.

Entities:  

Mesh:

Year:  1999        PMID: 10439362     DOI: 10.3109/10428199909050950

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  9 in total

1.  Low-grade systemic lymphoma with aggressive transformation in the lacrimal sac.

Authors:  N M Peter; R Khooshabeh
Journal:  Eye (Lond)       Date:  2012-03-02       Impact factor: 3.775

Review 2.  Richter's transformation in chronic lymphocytic leukemia.

Authors:  Apostolia-Maria Tsimberidou; Michael J Keating; William G Wierda
Journal:  Curr Hematol Malig Rep       Date:  2007-10       Impact factor: 3.952

3.  Expect the unexpected.

Authors:  I C Francis; G Wilcsek
Journal:  Br J Ophthalmol       Date:  2006-08       Impact factor: 4.638

4.  Parallel gene expression profiling of mantle cell lymphoma - how do we transform 'omics data into clinical practice.

Authors:  Ek Sara; Carl Ak Borrebaeck
Journal:  Curr Genomics       Date:  2007-05       Impact factor: 2.236

5.  Primary lymphoma of the lacrimal sac: an EORTC ophthalmic oncology task force study.

Authors:  L D Sjö; E Ralfkiaer; B R Juhl; J U Prause; T Kivelä; C Auw-Haedrich; F Bacin; M Carrera; S E Coupland; B Delbosc; N Ducrey; B Kantelip; J L Kemeny; P Meyer; N C Sjö; S Heegaard
Journal:  Br J Ophthalmol       Date:  2006-05-03       Impact factor: 4.638

Review 6.  Chromosome abnormalities with prognostic impact in B-cell chronic lymphocytic leukemia.

Authors:  Gábor Méhes
Journal:  Pathol Oncol Res       Date:  2005-12-31       Impact factor: 3.201

Review 7.  Immunohistochemistry in bone marrow pathology: a useful adjunct for morphologic diagnosis.

Authors:  Marcus Kremer; Leticia Quintanilla-Martínez; Jörg Nährig; Christoph von Schilling; Falko Fend
Journal:  Virchows Arch       Date:  2005-10-18       Impact factor: 4.064

8.  EZH2 and CD79B mutational status over time in B-cell non-Hodgkin lymphomas detected by high-throughput sequencing using minimal samples.

Authors:  Mauro Ajaj Saieg; William R Geddie; Scott L Boerner; Denis Bailey; Michael Crump; Gilda da Cunha Santos
Journal:  Cancer Cytopathol       Date:  2013-01-29       Impact factor: 5.284

9.  Clonal relationships in recurrent B-cell lymphomas.

Authors:  Seung Eun Lee; So Young Kang; Hae Yong Yoo; Seok Jin Kim; Won Seog Kim; Young Hyeh Ko
Journal:  Oncotarget       Date:  2016-03-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.